XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Share-based Compensation Expense
Total share-based compensation expense related to all share-based awards for the three and six months ended June 30, 2017 and 2016 was comprised of the following (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended
June 30,
 
2017
 
2016
 
2017
 
2016
Research and development:
 
 
 
 
 
 
 
   Stock options
$
2,563

 
$
1,215

 
$
5,016

 
$
2,476

   Restricted stock

 

 

 
30

   Warrants
16

 
4

 
33

 
15

Research and development share-based compensation expense
2,579

 
1,219

 
5,049

 
2,521

General and administrative:
 
 
 
 
 
 
 
   Stock options
1,993

 
1,559

 
3,948

 
3,269

   Restricted stock

 
510

 
409

 
1,129

   Warrants
139

 
53

 
288

 
127

General and administrative share-based compensation expense
2,132

 
2,122

 
4,645

 
4,525

Total share-based compensation expense included in expenses
$
4,711

 
$
3,341

 
$
9,694

 
$
7,046

Stock Options, Valuation Assumptions
The Company estimated the fair value of each stock option grant on the grant date using the Black-Scholes model with the following weighted-average assumptions:
 
Six Months Ended
June 30,
 
2017
 
2016
Expected volatility
137
%
 
143
%
Expected life
6.23 years

 
5.27 years

Risk-free interest rate
2.0
%
 
1.3
%
Dividend yield

 

Summary of Stock Option Activity
The Company’s 2013 Equity Plan stock option activity for the six months ended June 30, 2017 was comprised of the following:
 
Outstanding Stock Options and 2013 Equity Plan
 
Shares
Underlying
Stock Options
 
Weighted-
Average
Exercise Price
per Share
Outstanding at December 31, 2016
2,627,462

 
$
21.07

Granted
1,475,425

 
$
20.54

Exercised
(130,555
)
 
$
15.89

Forfeited
(74,217
)
 
$
21.97

Outstanding at June 30, 2017
3,898,115

 
$
21.03

Summary of Restricted Stock Activity
The Company’s restricted stock award activity for the six months ended June 30, 2017 was comprised of the following:
 
Number of
Shares
 
Weighted-
Average Grant
Date Fair
Market Value
Unvested at December 31, 2016
542,680

 
$
13.22

Vested
(542,680
)
 
$
13.22

Unvested at June 30, 2017

 
$